Standard BioTools Enters Termination, Waiver And Release Agreement With Illumina On July 24, 2026 - LAB News | RalliesStandard BioTools Enters Termination, Waiver And Release Agreement With Illumina On July 24, 2026
L
LAB• Agreement with Illumina
- Standard BioTools Inc. said it entered a termination, waiver and release agreement with Illumina on July 24, 2026, according to an SEC filing.
- The company said it received about $30 million in cash from Illumina for the waiver and release of obligations.
- Standard BioTools said it waived rights to the 2026 Illumina earnout and terminated royalty and license agreements.
V
•
